SHAWNA STEFFAN: Open Payments
NPI 1134401482 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 11 payments from 10 companies in 2025. Trend: 2023 $603 · 2024 $154 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Medtronic, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: SYMPLICITY G3, Veozah, REXULTI, FARXIGA, AREXVY, GEMTESA, Fluad, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
